Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

URLhttps://www.jnj.com/media-center/press-releases/jo
SourceJohnson & Johnson
Date Published02/18/2026

Additional Reshoring Information:

Company/Division name Johnson & Johnson
Parent companyJohnson & Johnson
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):500
Year reshoring announced:2026
Year reshoring implemented or to be implemented:2029
Capital investment ($):1000
City reshored to:Montgomery County
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharma
What domestic positive factors made reshoring more attractive?Eco-system synergies, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training
Find Reshoring Articles